Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8252718rdf:typepubmed:Citationlld:pubmed
pubmed-article:8252718lifeskim:mentionsumls-concept:C0042037lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C0086231lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C0024868lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C0439831lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:8252718lifeskim:mentionsumls-concept:C0044728lld:lifeskim
pubmed-article:8252718pubmed:issue12lld:pubmed
pubmed-article:8252718pubmed:dateCreated1994-1-13lld:pubmed
pubmed-article:8252718pubmed:abstractTextWe have developed a direct enzyme immunoassay (EIA) for quantifying immunoreactive 11-keto-thromboxane B2 (iKTXB) in unprocessed human urine. Cross-reactivity with other thromboxane metabolites and prostanoids was negligible. Analytical recovery of 11-keto-TXB2 in urine specimens was 97.4% to 99.8%. Total imprecision for two clinical specimens was 8.5% and 12.2%. Intake of acetylsalicylic acid decreased the measured concentration of iKTXB. Cardiopulmonary bypass, a procedure known to activate platelets, increased the mean excretion rate of iKTXB 10-fold. Simultaneous gas chromatography-mass spectrometry analysis of 11-keto-TXB2 and 11-keto-2,3-dinor TXB2 in urine specimens (n = 17) from healthy subjects indicated that urinary iKTXB concentrations measured by EIA represented a sum of the two 11-keto metabolites. We conclude that the direct EIA is sufficiently sensitive, rapid, simple, and specific to allow screening for alterations in thromboxane biosynthesis in patients.lld:pubmed
pubmed-article:8252718pubmed:languageenglld:pubmed
pubmed-article:8252718pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8252718pubmed:citationSubsetIMlld:pubmed
pubmed-article:8252718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8252718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8252718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8252718pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8252718pubmed:statusMEDLINElld:pubmed
pubmed-article:8252718pubmed:monthDeclld:pubmed
pubmed-article:8252718pubmed:issn0009-9147lld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:FanelliRRlld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:FoeghMMlld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:ChiabrandoCClld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:DjurupRRlld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:JörresAAlld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:SoerensenH...lld:pubmed
pubmed-article:8252718pubmed:authorpubmed-author:JoergensenP...lld:pubmed
pubmed-article:8252718pubmed:issnTypePrintlld:pubmed
pubmed-article:8252718pubmed:volume39lld:pubmed
pubmed-article:8252718pubmed:ownerNLMlld:pubmed
pubmed-article:8252718pubmed:authorsCompleteYlld:pubmed
pubmed-article:8252718pubmed:pagination2470-7lld:pubmed
pubmed-article:8252718pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:meshHeadingpubmed-meshheading:8252718-...lld:pubmed
pubmed-article:8252718pubmed:year1993lld:pubmed
pubmed-article:8252718pubmed:articleTitleRapid, direct enzyme immunoassay of 11-keto-thromboxane B2 in urine, validated by immunoaffinity/gas chromatography-mass spectrometry.lld:pubmed
pubmed-article:8252718pubmed:affiliationNovo Nordisk, Immunochemical Department, Bagsvaerd, Denmark.lld:pubmed
pubmed-article:8252718pubmed:publicationTypeJournal Articlelld:pubmed